Fiche personne
Territoire
Bourgogne
Statut
Hospitalo-Universitaire
Projets
Action incitative combinée, centrée sur les acteurs de soins primaires, pour améliorer le dépistage du cancer du col de l'utérus chez les femmes socialement défavorisées et non suivies : évaluation de l'efficacité et des enjeux éthiques et économiques (RESISTE)
2019 - Porteur du projet : Pr BARDOU Marc - Partenaire : Dr FENDER Muriel
Publications
Women's preferences for cervical cancer screening methods: a discrete choice experiment in Estonia and France.
Delisle V, Rochaix L, Bardou M, Uusküla A, Tisler A, Franc C
BMC Womens Health. 2026 04 22;:
The co-creation of a document to guide the use of self-sampling for human papillomavirus screening in Italy.
Bonvicini L, Iorio G, Ghirotto L, Auzzi N, Bardou M, Buus Bøje R, Kirkegaard P, Mantellini P, Giorgi Rossi P, ,
J Med Screen. 2026 04 3;:9691413261429385
Health equity under siege: the populist challenge to women's health in Europe.
Greenley R, Uusküla A, Kirkegaard P, Bardou M, McKee M,
Eur J Public Health. 2026 03 14;36(2):
Risk of cervical cancer and high-grade lesions in vulnerable women a systematic review and meta-analysis.
Hassine A, Tisler A, Martel M, Bardou M
Nat Commun. 2026 03 2;:
How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid-19.
Ben Ghezala I, Peiffer-Smadja N, Solas C, Nougairède A, Touret F, Bardou M
Clin Transl Sci. 2026 02;19(2):e70505
Exploring Emotional and Cognitive Perceptions of Cervical Cancer Screening and Self-Sampling Among Vulnerable Romanian Women: A Qualitative Study.
Pașca NM, Tăut D, Greenley R, Kirkegaard P, Bøje RB, McKee M, Bardou M, Băban AS,
Health Expect. 2025 12;28(6):e70485
Accelerating HPV-related cancer elimination - a meeting report.
Burdier FR, Bosch FX, Waheed DE, Teblick L, Poljak M, Baay M, de Sanjosé S, Bardou M, Baussano I, Man I, Franco EL, Vorsters A
BMC Proc. 2025 08 29;19(Suppl 19):22
'Knowing and Treating Kosaki/Penttinen syndrome' international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors.
Bouhatous YM, Bredrup C, Maurer A, Mirakovska L, Foster A, Kosaki K, Jost C, Demoulin JB, Luu M, Vabres P, Kurtz JE, Schaefer E, Guimier A, Cormier-Daire V, Lim D, Thompson S, Olson L, Kwon HR, Aguirre-Rodriguez C, Hernandez-Dorronsoro U, Martinez-Soroa I, Iznardo H, Mascaró JM, Baselga E, Kalantari S, Mussa A, Gazzin A, Carli D, Svinvik I, Mutlu-Albayrak H, Bluefeather S, Zarate Y, Takenouchi T, Naicker T, Chateau A, Gokhul A, Dube-Pule A, Haniffa M, Ong Peitee W, Nordgren A, Carpentier M, Binquet C, Briffaut AS, Bal L, Pond D, Rustad CF, Bardou M, Faivre L
J Med Genet. 2025 07 24;:
Lack of behavioural improvement with sirolimus in a patient with MTOR-related macrocephaly with pigmentary mosaicism: a new case report.
Bonniaud B, Luu M, Cormier C, Racine C, Espitalier A, Malbranche C, Rega A, Gaumet T, Kuentz P, Vabres P, Thauvin-Robinet C, Bardou M, Gay S, Faivre L, Delanne J
Eur J Med Genet. 2025 03 22;:105012
How can cervical screening meet the needs of vulnerable women? A qualitative comparative study with stakeholder perspectives from seven European countries.
Bøje RB, Bardou M, Mensah K, Rico Berrocal R, Bonvicini L, Iorio G, Auzzi N, Taut D, Pașca NM, Tisler A, Reintamm K, Uusküla A, Teixeira M, Firmino-Machado J, Amorim M, Baia I, Lunet N, Panayotova Y, Kotzeva T, Todorova I, Andersen B, Kirkegaard P,
BMJ Open. 2025 01 25;15(1):e090631
A phase II double-blind multicentre, placebo-controlled trial to assess the efficacy and safety of alpelisib (BYL719) in paediatric and adult patients with Megalencephaly-CApillary malformation Polymicrogyria syndrome (MCAP): the SESAM study protocol.
Luu M, Vabres P, Espitalier A, Maurer A, Garde A, Racine C, Carpentier M, Rega A, Loffroy R, Hadouiri N, Boddaert N, Curie A, Guibaud L, Chebbi M, Charligny J, Kuentz P, Canaud G, Bahi-Buisson N, Fleck C, Cransac A, Bardou M, Faivre L,
BMJ Open. 2024 12 20;14(12):e084614
Immunophenotyping and Activation Status of Maternal Lymphocytes to Predict Spontaneous Preterm Birth in Women With Threatened Preterm Labor: A Prospective Observational Study.
Wendremaire M, Hadi T, Lopez TE, Guy J, Neiers F, Garrido C, Simon E, Jaffal Z, Bernigal V, Bardou M, Lirussi F
Am J Reprod Immunol. 2024 12;92(6):e70015
IROND-L: study protocol for a French prospective, quasi-experimental, multicentre trial to examine the impact of a coordinated multidisciplinary approach for women victims of violence.
El-Khoury F, Ben Ghezala I, Hatem G, Jaffal Z, Soares A, Yacini L, Duchesne S, Dommergues M, Bretelle F, Eudeline S, Hoffmann P, Masse-Navette C, Layachi F, Maurice O, de Foucher de Careil T, Bardou M
BMJ Open. 2024 11 19;14(11):e086143
HPV-associated cancers among people living with HIV: nationwide population-based retrospective cohort study 2004-21 in Estonia.
Tisler A, Toompere K, Bardou M, Diaz J, Orumaa M, Uusküla A
Eur J Public Health. 2024 10 8;:
Expanding eligibility and improving quality of cervical cancer screening in Estonia: The 2021 reforms.
Rigby S, Greenley R, Uuskula A, Tisler A, Suurna M, Jesse M, Bardou M, McKee M,
Health Policy. 2024 04 24;144:105077
Post-traumatic stress disorders in women victims-survivors of intimate partner violence: a mixed-methods pilot study in a French coordinated structure.
Roland N, Delmas N, El Khoury F, Bardou A, Yacini L, Feldmann L, Hatem G, Mahdjoub S, Bardou M
BMJ Open. 2024 01 23;14(1):e075552
Experience and expectations of pharmacogenetic tests in France.
Verdez S, Bardou M, Duffourd Y, Luu M, Thauvin-Robinet C, Faivre L, Picard N
Therapie. 2023 07 17;:
Efficiency and effectiveness of intensive multidisciplinary follow-up of patients with stroke/TIA or myocardial infarction compared to usual monitoring: protocol of a pragmatic randomised clinical trial. DiVa (Dijon vascular) study.
Béjot Y, Soilly AL, Bardou M, Duloquin G, Pommier T, Laurent G, Cottin Y, Vadot L, Adam H, Boulin M, Giroud M
BMJ Open. 2023 04 26;13(4):e070197
Women and health professionals' perspectives on a conditional cash transfer programme to improve pregnancy follow-up: a qualitative analysis of the NAITRE randomised controlled study.
Bardou M, Meunier-Beillard N, Godard-Marceau A, Deruelle P, Virtos C, Eckman-Lacroix A, Debras E, Schmitz T,
BMJ Open. 2023 03 29;13(3):e067066
Exome sequencing allows detection of relevant pharmacogenetic variants in epileptic patients.
Verdez S, Thomas Q, Garret P, Verstuyft C, Tisserant E, Vitobello A, Mau-Them FT, Philippe C, Bardou M, Luu M, Bourredjem A, Callier P, Thauvin-Robinet C, Picard N, Faivre L, Duffourd Y
Pharmacogenomics J. 2022 12;22(5-6):258-263
Combined incentive actions, focusing on primary care professionals, to improve cervical cancer screening in women living in socioeconomically disadvantaged geographical areas: a study protocol of a hybrid cluster randomised effectiveness and implementatio
Hassine A, Antoni G, Fender M, Slama K, Léandri FX, Fanon JL, Auvray C, Jaffar Bandjee MC, Traversier N, Fagour L, Rochaix L, Fiorina C, Pourette D, Opigez E, Dumont A, Bardou M, Study Group R
BMJ Open. 2022 11 23;12(11):e065952
Association between Obstetric Complications and Intravitreal Anti-Vascular Endothelial Growth Factor Agents or Intravitreal Corticosteroids.
Ben Ghezala I, Mariet AS, Benzenine E, Bardou M, Bron AM, Gabrielle PH, Baudin F, Quantin C, Creuzot-Garcher C
J Pers Med. 2022 08 25;12(9):
An update on drug-drug interactions associated with proton pump inhibitors.
Ben Ghezala I, Luu M, Bardou M
Expert Opin Drug Metab Toxicol. 2022 07 4;:
Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine.
Launay O, Cachanado M, Luong Nguyen LB, Ninove L, Lachâtre M, Ben Ghezala I, Bardou M, Schmidt-Mutter C, Lacombe K, Laine F, Allain JS, Botelho-Nevers E, Tavolacci MP, Chidiac C, Pavese P, Dussol B, Priet S, Deplanque D, Touati A, Curci L, Konate E, Ben Hamouda N, Besbes A, Nubret E, Capelle F, Berard L, Rousseau A, Tartour E, Simon T, de Lamballerie X
N Engl J Med. 2022 06 29;:
Violence against women and perceived health: An observational survey of patients treated in the multidisciplinary structure 'The Women's House' and two Family Planning Centres in the metropolitan Paris area.
Roland N, Ahogbehossou Y, Hatem G, Yacini L, Feldmann L, Saurel-Cubizolles MJ, Bardou M
Health Soc Care Community. 2022 Mar 22;:
Leptin-Induced HLA-G Inhibits Myometrial Contraction and Differentiation.
Wendremaire M, Lopez TE, Barrichon M, Zhang H, Hadi T, Ye XY, Neiers F, Bardou M, Sagot P, Garrido C, Lirussi F
Cells. 2022 Mar 10;11(6):
Assessing the Acceptability of Home-Based HPV Self-Sampling: A Qualitative Study on Cervical Cancer Screening Conducted in Reunion Island Prior to the RESISTE Trial.
Pourette D, Cripps A, Guerrien M, Desprès C, Opigez E, Bardou M, Dumont A
Cancers (Basel). 2022 Mar 8;14(6):
Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel-Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm study.
Luu M, Vabres P, Devilliers H, Loffroy R, Phan A, Martin L, Morice-Picard F, Petit F, Willems M, Bessis D, Jacquemont ML, Maruani A, Chiaverini C, Mirault T, Clayton-Smith J, Carpentier M, Fleck C, Maurer A, Yousfi M, Parker VER, Semple RK, Bardou M, Faivre L
Genet Med. 2021 Aug 12;:
Small Molecule Drugs in Inflammatory Bowel Diseases.
Ben Ghezala I, Charkaoui M, Michiels C, Bardou M, Luu M
Pharmaceuticals (Basel). 2021 Jun 30;14(7):
Safety, Efficacy, and Outcomes of N-Butyl Cyanoacrylate Glue Injection through the Endoscopic or Radiologic Route for Variceal Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis.
Chevallier O, Guillen K, Comby PO, Mouillot T, Falvo N, Bardou M, Midulla M, Aho-Glélé LS, Loffroy R
J Clin Med. 2021 May 25;10(11):
Efficacy, safety and outcomes of transcatheter arterial embolization with N-butyl cyanoacrylate glue for non-variceal gastrointestinal bleeding: A systematic review and meta-analysis.
Chevallier O, Comby PO, Guillen K, Pellegrinelli J, Mouillot T, Falvo N, Bardou M, Midulla M, Aho-Glélé S, Loffroy R
Diagn Interv Imaging. 2021 Apr 20;:
Relative risk rather than absolute risk reduction should be preferred to sensitise the public to preventive actions.
Chapelle N, Martel M, Barkun AN, Bardou M
Gut. 2021 Apr 2;:
Comparative benefit and cost-effectiveness of mailed-out faecal immunochemical tests vs collection at the general practitioner.
Peterse EFP, Osoro CB, Bardou M, Lansdorp-Vogelaar I
Aliment Pharmacol Ther. 2021 Mar 8;:
Clinical and neuroimaging findings in 33 patients with MCAP syndrome: a survey to evaluate relevant endpoints for future clinical trials.
Garde A, Guibaud L, Goldenberg A, Petit F, Dard R, Roume J, Mazereeuw-Hautier J, Chassaing N, Lacombe D, Morice-Picard F, Toutain A, Arpin S, Boccara O, Touraine R, Blanchet P, Coubes C, Willems M, Pinson L, Khau Van Kien P, Chiaverini C, Giuliano F, Alessandri JL, Mathieu-Dramard M, Morin G, Bursztejn AC, Mignot C, Doummar D, Di Rocco F, Cornaton J, Nicolas C, Gautier E, Luu M, Bardou M, Sorlin A, Philippe C, Edery P, Rossi M, Carmignac V, Thauvin-Robinet C, Vabres P, Faivre L
Clin Genet. 2021 Jan 7;:
Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virus.
Brayette A, Essig M, Carrier P, Debette-Gratien M, Labrunie A, Alain S, Maynard M, Ganne-Carrié N, Nguyen-Khac E, Pinet P, De Ledinghen V, Renou C, Mathurin P, Vanlemmens C, Di Martino V, Gervais A, Foucher J, Isabelle FH, Vergniol J, Hourmand-Ollivier I, Cohen D, Duval X, Poynard T, Bardou M, Abergel A, Dao MT, Thévenot T, Hiriart JB, Canva V, Lassailly G, Aurières C, Boyer N, Thabut D, Bernard PH, Schnee M, Larrey D, Hanslik B, Hommel S, Jacques J, Loustaud-Ratti V
World J Hepatol. 2020 Dec 27;12(12):1326-1340
Ten-year experience with arterial embolization for peptic ulcer bleeding: N-butyl cyanoacrylate glue versus other embolic agents.
Loffroy R, Desmyttere AS, Mouillot T, Pellegrinelli J, Facy O, Drouilllard A, Falvo N, Charles PE, Bardou M, Midulla M, Aho-Gléglé S, Chevallier O
Eur Radiol. 2020 Oct 31;:
Recent advances in clinical practice: colorectal cancer chemoprevention in the average-risk population.
Chapelle N, Martel M, Toes-Zoutendijk E, Barkun AN, Bardou M
Gut. 2020 Sep 28;:
The pharmacotherapeutic management of gastroesophageal reflux disease (GERD).
Chapelle N, Ben Ghezala I, Barkun A, Bardou M
Expert Opin Pharmacother. 2020 Sep 7;:1-9
Compassionate use of everolimus for refractory epilepsy in a patient with MTOR mosaic mutation.
Hadouiri N, Darmency V, Guibaud L, Arzimanoglou A, Sorlin A, Carmignac V, Rivière JB, Huet F, Luu M, Bardou M, Thauvin-Robinet C, Vabres P, Faivre L
Eur J Med Genet. 2020 Aug 14;:104036
Oral anticoagulants and risk of acute liver injury in patients with nonvalvular atrial fibrillation: a propensity-weighted nationwide cohort study.
Maura G, Bardou M, Billionnet C, Weill A, Drouin J, Neumann A
Sci Rep. 2020 Jul 15;10(1):11624
Current role of cyanoacrylate glue transcatheter embolization in the treatment of acute nonvariceal gastrointestinal bleeding.
Loffroy R, Mouillot T, Bardou M, Chevallier O
Expert Rev Gastroenterol Hepatol. 2020 Jun 30;:
Management of Nonvariceal Upper Gastrointestinal Bleeding.
Barkun AN, Laine L, Leontiadis GI, Bardou M
Ann. Intern. Med.. 2020 Apr 21;172(8):573
Kosaki overgrowth syndrome: a novel pathogenic variant in PDGFRB and expansion of the phenotype including cerebrovascular complications.
Foster A, Chalot B, Antoniadi T, Schaefer E, Keelagher R, Ryan G, Thomas Q, Philippe C, Bruel AL, Sorlin A, Thauvin-Robinet C, Bardou M, Luu M, Quenardelle V, Wolff V, Woodley J, Vabres P, Lim D, Igbokwe R, Joseph A, Walker H, Jester A, Ellenbogen J, Johnson D, Rooke B, Moss C, Cole T, Faivre L
Clin. Genet.. 2020 Apr 14;:
Consensus Recommendations for the Use of Simulation in Therapeutic Patient Education.
Penneçot C, Gagnayre R, Ammirati C, Bertin É, Capelle D, Cheraitia E, Chiniara G, David V, De La Tribonnière X, Decelle B, Derambure P, Gignon M, Greffier C, Gross O, Lalande A, Lartiguet P, Letallec C, Mahé C, Mero Y, Mohammed R, Pétré B, Picchiottino P, Pougheon-Bertrand D, Secheresse T, Vaillant G, Van der Schueren-Etévé M, Verdier J, Benhaberou-Brun D, Bardou M, Marchand C
Simul Healthc. 2020 Feb;15(1):30-38
Monitoring HSP70 exosomes in cancer patients' follow up: a clinical prospective pilot study.
Chanteloup G, Cordonnier M, Isambert N, Bertaut A, Hervieu A, Hennequin A, Luu M, Zanetta S, Coudert B, Bengrine L, Desmoulins I, Favier L, Lagrange A, Pages PB, Gutierrez I, Lherminier J, Avoscan L, Jankowski C, Rébé C, Chevriaux A, Padeano MM, Coutant C, Ladoire S, Causeret S, Arnould L, Charon-Barra C, Cottet V, Blanc J, Binquet C, Bardou M, Garrido C, Gobbo J
J Extracell Vesicles. 2020 ;9(1):1766192
Use of proton pump inhibitors in adults in France: a nationwide drug utilization study.
Lassalle M, Le Tri T, Bardou M, Biour M, Kirchgesner J, Rouby F, Dumarcet N, Zureik M, Dray-Spira R
Eur. J. Clin. Pharmacol.. 2019 Dec 14;:
Editorial: how safe is it to administer the BCG vaccination to babies exposed to anti-TNFα medications antenatally? Authors' reply.
Luu M, Benzenine E, Barkun A, Doret M, Michiels C, Degand T, Quantin C, Bardou M
Aliment. Pharmacol. Ther.. 2019 Dec;50(11-12):1240-1241
Participation in faecal immunochemical testing-based colorectal cancer screening programmes in the northwest of Europe.
Toes-Zoutendijk E, Portillo I, Hoeck S, de Brabander I, Perrin P, Dubois C, van Leerdam M, Lansdorp-Vogelaar I, Bardou M
J Med Screen. 2019 Oct 23;:969141319879712
Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group.
Barkun AN, Almadi M, Kuipers EJ, Laine L, Sung J, Tse F, Leontiadis GI, Abraham NS, Calvet X, Chan FKL, Douketis J, Enns R, Gralnek IM, Jairath V, Jensen D, Lau J, Lip GYH, Loffroy R, Maluf-Filho F, Meltzer AC, Reddy N, Saltzman JR, Marshall JK, Bardou M
Ann. Intern. Med.. 2019 Oct 22;:
Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed in utero to anti-TNFα agents: a French nationwide population-based cohort.
Luu M, Benzenine E, Barkun A, Doret M, Michiels C, Degand T, Quantin C, Bardou M
Aliment. Pharmacol. Ther.. 2019 Oct 15;:
Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years.
Vuik FE, Nieuwenburg SA, Bardou M, Lansdorp-Vogelaar I, Dinis-Ribeiro M, Bento MJ, Zadnik V, Pellisé M, Esteban L, Kaminski MF, Suchanek S, Ngo O, Májek O, Leja M, Kuipers EJ, Spaander MC
Gut. 2019 May 16;:
Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests.
Thauvin-Robinet C, Thevenon J, Nambot S, Delanne J, Kuentz P, Bruel AL, Chassagne A, Cretin E, Pelissier A, Peyron C, Gautier E, Lehalle D, Jean-Marçais N, Callier P, Mosca-Boidron AL, Vitobello A, Sorlin A, Tran Mau-Them F, Philippe C, Vabres P, Demougeot L, Poé C, Jouan T, Chevarin M, Lefebvre M, Bardou M, Tisserant E, Luu M, Binquet C, Deleuze JF, Verstuyft C, Duffourd Y, Faivre L
Eur. J. Hum. Genet.. 2019 Apr 24;:
Prophylaxis for stress related gastrointestinal bleeding in the ICU: Should we adjust to each patient's individual risk?
Quenot JP, Dargent A, Barkun A, Bardou M
Anaesth Crit Care Pain Med. 2019 Feb 5;:
An update on the latest chemical therapies for reflux esophagitis in children.
Bardou M, Fortinsky KJ, Chapelle N, Luu M, Barkun A
Expert Opin Pharmacother. 2018 Nov 29;:1-9
How can we best monitor 5FU administration to maximize benefit to risk ratio?
Goirand F, Lemaitre F, Launay M, Tron C, Chatelut E, Boyer JC, Bardou M, Schmitt A
Expert Opin Drug Metab Toxicol. 2018 Nov 19;:
Proton-Pump Inhibitor Prophylaxis in the ICU - Benefits Worth the Risks?
Barkun A, Bardou M
N. Engl. J. Med.. 2018 Oct 24;:
Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum.
Parker VER, Keppler-Noreuil KM, Faivre L, Luu M, Oden NL, De Silva L, Sapp JC, Andrews K, Bardou M, Chen KY, Darling TN, Gautier E, Goldspiel BR, Hadj-Rabia S, Harris J, Kounidas G, Kumar P, Lindhurst MJ, Loffroy R, Martin L, Phan A, Rother KI, Widemann BC, Wolters PL, Coubes C, Pinson L, Willems M, Vincent-Delorme C, ,Vabres P, Semple RK, Biesecker LG
Genet. Med.. 2018 Oct 1;:
Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature.
Delanne J, Nambot S, Chassagne A, Putois O, Pelissier A, Peyron C, Gautier E, Thevenon J, Cretin E, Bruel AL, Goussot V, Ghiringhelli F, Boidot R, Tran-Mau-Them F, Philippe C, Vitobello A, Demougeot L, Vernin C, Lapointe AS, Bardou M, Luu M, Binquet C, Lejeune C, Joly L, Juif C, Baurand A, Sawka C, Bertolone G, Duffourd Y, Sanlaville D, Pujol P, Geneviève D, Houdayer F, Thauvin-Robinet C, Faivre L
Eur J Med Genet. 2018 Aug 27;:
Prophylactic angiographic embolisation in high-risk peptic ulcer bleeding after achieved endoscopic control: maximising outcomes.
Loffroy R, Bardou M
Gut. 2018 Jul 11;:
Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION).
Luu M, Benzenine E, Doret M, Michiels C, Barkun A, Degand T, Quantin C, Bardou M
Am. J. Gastroenterol.. 2018 Jul 2;:
Approaches to manage 'affordability' of high budget impact medicines in key EU countries.
Flume M, Bardou M, Capri S, Sola-Morales O, Cunningham D, Levin LA, Postma MJ, Touchot N
J Mark Access Health Policy. 2018 ;6(1):1478539
NAITRE study on the impact of conditional cash transfer on poor pregnancy outcomes in underprivileged women: protocol for a nationwide pragmatic cluster-randomised superiority clinical trial in France.
Bardou M, Crépon B, Bertaux AC, Godard-Marceaux A, Eckman-Lacroix A, Thellier E, Falchier F, Deruelle P, Doret M, Carcopino-Tusoli X, Schmitz T, Barjat T, Morin M, Perrotin F, Hatem G, Deneux-Tharaux C, Fournel I, Laforet L, Meunier-Beillard N, Duflo E, Le Ray I,
BMJ Open. 2017 Oct 30;7(10):e017321
Beta3 adrenergic receptor stimulation in human macrophages inhibits NADPHoxidase activity and induces catalase expression via PPARγ activation.
Hadi T, Douhard R, Dias AMM, Wendremaire M, Pezzè M, Bardou M, Sagot P, Garrido C, Lirussi F
Biochim. Biophys. Acta. 2017 Jul;1864(10):1769-1784
Efficacy of a Novel Prefilled, Single-Use, Needle-Free Device (Zeneo(®)) in Achieving Intramuscular Agent Delivery: An Observational Study.
Bardou M, Luu M, Walker P, Auriel C, Castano X
Adv Ther. 2017 Jan;34(1):252-260
Pharmacokinetics, pharmacodynamics and clinical efficacy of omalizumab for the treatment of asthma.
Luu M, Bardou M, Bonniaud P, Goirand F
Expert Opin Drug Metab Toxicol. 2016 Dec;12(12):1503-1511
Influenza during pregnancy: Incidence, vaccination coverage and attitudes toward vaccination in the French web-based cohort G-GrippeNet.
Loubet P, Guerrisi C, Turbelin C, Blondel B, Launay O, Bardou M, Goffinet F, Colizza V, Hanslik T, Kernéis S,
Vaccine. 2016 Apr;34(20):2390-6
Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy.
Clausse V, Goloudina AR, Uyanik B, Kochetkova EY, Richaud S, Fedorova OA, Hammann A, Bardou M, Barlev NA, Garrido C, Demidov ON
Cell Death Dis. 2016 Apr;7:e2195
First nationwide web-based surveillance system for influenza-like illness in pregnant women: participation and representativeness of the French G-GrippeNet cohort.
Loubet P, Guerrisi C, Turbelin C, Blondel B, Launay O, Bardou M, Blanchon T, Bonmarin I, Goffinet F, Ancel PY, Colizza V, Hanslik T, Kernéis S
BMC Public Health. 2016 Mar;16:253
Feasibility and attractiveness of indication value-based pricing in key EU countries.
Flume M, Bardou M, Capri S, Sola-Morales O, Cunningham D, Levin LA, Touchot N,
J Mark Access Health Policy. 2016 ;4:
Role of Medical Therapy for Nonvariceal Upper Gastrointestinal Bleeding.
Fortinsky KJ, Bardou M, Barkun AN
Gastrointest Endosc Clin N Am. 2015 Jul;25(3):463-78
Glutathione prevents preterm parturition and fetal death by targeting macrophage-induced reactive oxygen species production in the myometrium.
Hadi T, Bardou M, Mace G, Sicard P, Wendremaire M, Barrichon M, Richaud S, Demidov O, Sagot P, Garrido C, Lirussi F
FASEB J. 2015 Jun;29(6):2653-66
Safety of medication options for treating pediatric esophagitis.
Bardou M, Fortinsky KJ
Expert Opin Drug Saf. 2015 Apr 26:1-10.
Dose-dependent biphasic leptin-induced proliferation is caused by non-specificIL-6/NFkappaB pathway activation in human myometrial cells.
Barrichon M, Hadi T, Wendremaire M, Ptasinski C, Seigneuric R, Marcion G, Delignette M, Marchet J, Dumas M, Sagot P, Bardou M, Garrido C, Lirussi F
Br J Pharmacol. 2015 Feb 5
Stress-related mucosal disease in the critically ill patient.
Bardou M, Quenot JP, Barkun A
Nat Rev Gastroenterol Hepatol. 2015 Feb;12(2):98-107
Changes in maternal blood inflammatory markers as a predictor of chorioamnionitis: a prospective multicenter study.
Le Ray I, Mace G, Sediki M, Lirussi F, Riethmuller D, Lentz N, Ramanah R, Hoyek T, Spagnolo G, Laurent N, Goirand F, Sagot P, Bardou M
Am J Reprod Immunol. 2015 Jan;73(1):79-90
Pharmacokinetic evaluation of esomeprazole for the treatment of gastroesophageal reflux disease.
Goirand F, Le Ray I, Bardou M
Expert Opin Drug Metab Toxicol. 2014 Sep;10(9):1301-11
Can the presence of endoscopic high-risk stigmata be predicted before endoscopy? A multivariable analysis using the RUGBE database.
Chen YI, Wyse J, Barkun A, Bardou M, Gralnek I, Martel M
Can J Gastroenterol Hepatol. 2014 Jun;28(6):301-4.
Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial.
Boulin M, Hillon P, Cercueil JP, Bonnetain F, Dabakuyo S, Minello A, Jouve JL, Lepage C, Bardou M, Wendremaire M, Guerard P, Denys A, Grandvuillemin A, Chauffert B, Bedenne L, Guiu B
Aliment Pharmacol Ther. 2014 Jun;39(11):1301-13
Systemic increase in human maternal circulating CD14+CD16- MCP-1+ monocytes as a marker of labor.
Bardou M, Hadi T, Mace G, Pesant M, Debermont J, Barrichon M, Wendremaire M, Laurent N, Sagot P, Lirussi F
Am J Obstet Gynecol. 2014 Jan;210(1):70.e1-9
The increasing need for health-economic assessment in gastrointestinal and liver diseases.
Bardou M, Martin J
Best Pract Res Clin Gastroenterol. 2013 Dec;27(6):829-30
Treatment of pancreatic cancer: A narrative review of cost-effectiveness studies.
Bardou M, Le Ray I
Best Pract Res Clin Gastroenterol. 2013 Dec;27(6):881-92
Republished: obesity and colorectal cancer.
Bardou M, Barkun AN, Martel M
Postgrad Med J. 2013 Sep;89(1055):519-33
Biphasic Erk1/2 activation sequentially involving Gs and Gi signaling is required in beta3-adrenergic receptor-induced primary smooth muscle cell proliferation.
Hadi T, Barrichon M, Mourtialon P, Wendremaire M, Garrido C, Sagot P, Bardou M, Lirussi F
Biochim Biophys Acta. 2013 May;1833(5):1041-51
Failure to renew prescriptions for gastroprotective agents to patients on continuous nonsteroidal anti-inflammatory drugs increases rate of upper gastrointestinal injury.
Le Ray I, Barkun AN, Vauzelle-Kervroedan F, Bardou M
Clin Gastroenterol Hepatol. 2013 May;11(5):499-504.e1
Controversies in stress ulcer bleeding prophylaxis arise from differences in the quality of the evidence.
Barkun AN, Bardou M, Martel M
Anaesth Intensive Care. 2013 Mar;41(2):269-70.
Stress ulcer prophylaxis in the ICU: who, when, and how?
Bardou M, Barkun AN
Crit Care Med. 2013 Mar;41(3):906-7
Effects of leptin on lipopolysaccharide-induced remodeling in an in vitro model of human myometrial inflammation.
Wendremaire M, Mourtialon P, Goirand F, Lirussi F, Barrichon M, Hadi T, Garrido C, Le Ray I, Dumas M, Sagot P, Bardou M
Biol Reprod. 2013 Feb 21;88(2):45
Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors.
Isambert N, Fumoleau P, Paul C, Ferrand C, Zanetta S, Bauer J, Ragot K, Lizard G, Jeannin JF, Bardou M
BMC Cancer. 2013 Apr 2;13:172
Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matching.
Le Ray I, Dabakuyo S, Crehange G, Bardou M, Arnould L, Fraisse J, Fumoleau P, Coudert B, Causeret S, Arveux P, Maingon P, Bonnetain F
Eur J Cancer. 2012 Oct;48(15):2300-10
Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis.
El Ouali S, Barkun AN, Wyse J, Romagnuolo J, Sung JJ, Gralnek IM, Bardou M, Martel M
Gastrointest Endosc. 2012 Aug;76(2):283-92
Accuracy of blood transfusion in postpartum hemorrhage to assess maternal morbidity.
Sagot P, Mourtialon P, Benzenine E, Bardou M, Ferdynus C, Morel P, Quantin C
Eur J Obstet Gynecol Reprod Biol. 2012 Jun;162(2):160-4
Conflicts of interest ethics: silencing expertise in the development of international clinical practice guidelines.
Jones DJ, Barkun AN, Lu Y, Enns R, Sinclair P, Martel M, Gralnek I, Bardou M, Kuipers EJ, Sung J
Ann Intern Med. 2012 Jun 5;156(11):809-16, W-283.
Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis.
Barkun AN, Bardou M, Pham CQ, Martel M
Am J Gastroenterol. 2012 Apr;107(4):507-20; quiz 521
Incidence of Abcd1 level on the induction of cell death and organelle dysfunctions triggered by very long chain fatty acids and TNF-alpha on oligodendrocytes and astrocytes.
Baarine M, Ragot K, Athias A, Nury T, Kattan Z, Genin EC, Andreoletti P, Menetrier F, Riedinger JM, Bardou M, Lizard G
Neurotoxicology. 2012 Mar;33(2):212-28
Management of patients with nonvariceal upper gastrointestinal bleeding.
Greenspoon J, Barkun A, Bardou M, Chiba N, Leontiadis GI, Marshall JK, Metz DC, Romagnuolo J, Sung J
Clin Gastroenterol Hepatol. 2012 Mar;10(3):234-9
Diagnosis and management of nonvariceal upper gastrointestinal bleeding.
Bardou M, Benhaberou-Brun D, Le Ray I, Barkun AN
Nat Rev Gastroenterol Hepatol. 2012 Jan 10;9(2):97-104
How early should endoscopy be performed in suspected upper gastrointestinal bleeding?
Barkun AN, Bardou M, Kuipers EJ, Sung J
Am J Gastroenterol. 2012 Feb;107(2):328-9
Effects of leptin on lipopolysaccharide-induced myometrial apoptosis in an in vitro human model of chorioamnionitis.
Wendremaire M, Bardou M, Peyronel C, Hadi T, Sagot P, Morrison JJ, Lirussi F
Am J Obstet Gynecol. 2011 Oct;205(4):363.e1-9
Erythromycin is preferable to metoclopramide as a prokinetic in acute upper GI bleeding Response
Barkun AN, Bardou M, Martel M, Gralnek IM, Sung J
Gastrointest Endosc. 2011 Jul;74(1):234-5.
Systematic review: the presenting international normalised ratio (INR) as a predictor of outcome in patients with upper nonvariceal gastrointestinal bleeding.
Shingina A, Barkun AN, Razzaghi A, Martel M, Bardou M, Gralnek I
Aliment Pharmacol Ther. 2011 May;33(9):1010-8
Prokinetics in acute upper GI bleeding: a meta-analysis.
Barkun AN, Bardou M, Martel M, Gralnek IM, Sung JJ
Gastrointest Endosc. 2010 Dec;72(6):1138-45.
Effect of statin therapy on colorectal cancer.
Bardou M, Barkun A, Martel M
Gut. 2010 Nov;59(11):1572-85
High-dose vs non-high-dose PPIs after endoscopic treatment in patients with bleeding peptic ulcer: current evidence is insufficient to claim equivalence.
Calvet X, Barkun A, Bardou M, Sung J, Kuipers EJ
Arch Intern Med. 2010 Oct 11;170(18):1698-9; author reply 1700.
Measuring quality of care in patients with nonvariceal upper gastrointestinal hemorrhage: development of an explicit quality indicator set.
Kanwal F, Barkun A, Gralnek IM, Asch SM, Kuipers EJ, Bardou M, Sung J, Enns R, Agreus L, Armstrong D, Spiegel BM
Am J Gastroenterol. 2010 Aug;105(8):1710-8.
Methodology for randomized trials of patients with nonvariceal upper gastrointestinal bleeding: recommendations from an international consensus conference.
Laine L, Spiegel B, Rostom A, Moayyedi P, Kuipers EJ, Bardou M, Sung J, Barkun AN
Am J Gastroenterol. 2010 Mar;105(3):540-50
SAR150640, a selective beta3-adrenoceptor agonist, prevents human myometrial remodelling and activation of matrix metalloproteinase in an in vitro model of chorioamnionitis.
Lirussi F, O'Brien M, Wendremaire M, Goirand F, Sagot P, Dumas M, Morrison JJ, Bardou M
Br J Pharmacol. 2010 Mar;159(6):1354-66
The prognosis of patients having received optimal therapy for nonvariceal upper gastrointestinal bleeding might be worse in daily practice than in randomized clinical trials.
Fein F, Weber A, Koch S, Festou N, Dupont-Gossard AC, Cervoni JP, Monnet E, Bardou M, Carbonnel F
Eur J Gastroenterol Hepatol. 2010 Mar;22(3):361-7.
Aspirin withdrawal in acute peptic ulcer bleeding: are we harming patients?
Barkun AN, Bardou M
Ann Intern Med. 2010 Jan 5;152(1):52-3, W-12
International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding.
Barkun AN, Bardou M, Kuipers EJ, Sung J, Hunt RH, Martel M, Sinclair P
Ann Intern Med. 2010 Jan 19;152(2):101-13.
Preventing the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: from risk factor identification to risk factor intervention.
Bardou M, Barkun AN
Joint Bone Spine. 2010 Jan;77(1):6-12
Relevance of new recommendations on routine antenatal prevention of rhesus immunization: an appraisal based on a retrospective analysis of all cases observed in two French administrative areas of 3 million inhabitants.
Boulet S, Krause C, Tixier H, Bardou M, Sagot P
Eur J Obstet Gynecol Reprod Biol. 2009 Sep;146(1):65-70
Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses.
Barkun AN, Martel M, Toubouti Y, Rahme E, Bardou M
Gastrointest Endosc. 2009 Apr;69(4):786-99
Intravenous proton pump inhibitors: an evidence-based review of their use in gastrointestinal disorders.
Bardou M, Martin J, Barkun A
Drugs. 2009;69(4):435-48
Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.
Rakotoniaina Z, Guerard P, Lirussi F, Rochette L, Dumas M, Goirand F, Bardou M
Naunyn Schmiedebergs Arch Pharmacol. 2008 Sep;378(3):241-51
Management of acute bleeding from a peptic ulcer.
Gralnek IM, Barkun AN, Bardou M
N Engl J Med. 2008 Aug 28;359(9):928-37.
Cost-effectiveness of proton-pump inhibition before endoscopy in upper gastrointestinal bleeding.
Al-Sabah S, Barkun AN, Herba K, Adam V, Fallone C, Mayrand S, Pomier-Layrargues G, Kennedy W, Bardou M
Clin Gastroenterol Hepatol. 2008 Apr;6(4):418-25
Pantoprazole: from drug metabolism to clinical relevance.
Bardou M, Martin J
Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):471-83.
ADRB3 adrenergic receptor is a key regulator of human myometrial apoptosis and inflammation during chorioamnionitis.
Lirussi F, Rakotoniaina Z, Madani S, Goirand F, Breuiller-Fouche M, Leroy MJ, Sagot P, Morrison JJ, Dumas M, Bardou M
Biol Reprod. 2008 Mar;78(3):497-505
Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help.
Garay RP, Viens P, Bauer J, Normier G, Bardou M, Jeannin JF, Chiavaroli C
Eur J Pharmacol. 2007 Jun 1;563(1-3):1-17
In vitro and in vivo pharmacological characterization of ethyl-4-[trans-4-[((2S)-2-hydroxy-3-[4-hydroxy-3[(methylsulfonyl)amino]-ph enoxy]propyl) amino]cyclohexyl]benzoate hydrochloride (SAR150640), a new potent and selective human beta3-adrenoceptor agon
Croci T, Cecchi R, Marini P, Rouget C, Viviani N, Germain G, Guagnini F, Fradin Y, Descamps L, Pascal M, Advenier C, Breuiller-Fouche M, Leroy MJ, Bardou M
J Pharmacol Exp Ther. 2007 Jun;321(3):1118-26
Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study.
Rahme E, Bardou M, Dasgupta K, Toubouti Y, Ghosn J, Barkun AN
Rheumatology (Oxford). 2007 Feb;46(2):265-72
Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?
Bardou M, Rouget C, Breuiller-Fouche M, Loustalot C, Naline E, Sagot P, Frydman R, Morcillo EJ, Advenier C, Leroy MJ, Morrison JJ
BMC Pregnancy Childbirth. 2007 Jun 1;7 Suppl 1:S14.
The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
Guerard P, Rakotoniaina Z, Goirand F, Rochette L, Dumas M, Lirussi F, Bardou M
Naunyn Schmiedebergs Arch Pharmacol. 2006 Sep;373(6):401-14
Pro/con debate: octreotide has an important role in the treatment of gastrointestinal bleeding of unknown origin?
Arabi Y, Al Knawy B, Barkun AN, Bardou M
Crit Care. 2006;10(4):218.
Stimulation of the ADRB3 adrenergic receptor induces relaxation of human placental arteries: influence of preeclampsia.
Rouget C, Barthez O, Goirand F, Leroy MJ, Breuiller-Fouche M, Rakotoniaina Z, Guerard P, Morcillo EJ, Advenier C, Sagot P, Cabrol D, Dumas M, Bardou M
Biol Reprod. 2006 Jan;74(1):209-16
Response to "Potentially flawed interpretation of data by Andriulli et al.".
Barkun AN, Thomson A, Marshall J, Bardou M
Am J Gastroenterol. 2005 Sep;100(9):2133; author reply 2133-4.
Beta3-adrenoceptor is the predominant beta-adrenoceptor subtype in human myometrium and its expression is up-regulated in pregnancy.
Rouget C, Bardou M, Breuiller-Fouche M, Loustalot C, Qi H, Naline E, Croci T, Cabrol D, Advenier C, Leroy MJ
J Clin Endocrinol Metab. 2005 Mar;90(3):1644-50
Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding.
Bardou M, Toubouti Y, Benhaberou-Brun D, Rahme E, Barkun AN
Aliment Pharmacol Ther. 2005 Mar 15;21(6):677-86.
Non-steroidal anti-inflammatory and cytoprotective drug co-prescription in general practice. A general practitioner-based survey in France.
Clinard F, Bardou M, Sgro C, Lefevre N, Raphael F, Paille F, Dumas M, Hillon P, Bonithon-Kopp C
Eur J Clin Pharmacol. 2001 Dec;57(10):737-43.
Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-based survey in France.
Clinard F, Sgro C, Bardou M, Dumas M, Hillon P, Bonithon-Kopp C
Pharmacoepidemiol Drug Saf. 2001 Jun-Jul;10(4):329-38.
